ArticleOncotarget2017
TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer.
Dai Yuedi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ArticleOncotarget2017
Dai Yuedi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.